Related Experiment Video
Updated: Jun 22, 2025

Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture
Published on: October 12, 2018
The vaginal microbiome and HIV transmission dynamics
Emily M Cherenack1, Courtney A Broedlow2, Nichole R Klatt2
1Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, Florida.
A nonoptimal vaginal microbiome increases HIV transmission risk in women. Current treatments are ineffective, necessitating the development of women-centered solutions to modify the vaginal microbiome and reduce HIV acquisition.
Area of Science:
- Reproductive Health
- Microbiome Research
- Infectious Disease Epidemiology
Background:
- The vaginal microbiome plays a critical role in women's health, influencing susceptibility to infections.
- A nonoptimal vaginal microbiome, characterized by low levels of beneficial Lactobacillus species, is linked to increased HIV transmission risk.
- Understanding the complex interplay between the vaginal microbiome and host immunity is crucial for developing effective HIV prevention strategies.
Purpose of the Study:
- To review recent advancements in understanding the vaginal microbiome's role in HIV transmission.
- To summarize innovative research characterizing host-bacteria interactions in the female reproductive tract.
- To identify potential therapeutic targets for reducing HIV acquisition.
Main Methods:
- Multi-omics approaches to analyze microbial communities and host responses.
- Experimental studies investigating the functional impact of microbiome alterations.
- Translational research bridging basic science findings to clinical applications.
Main Results:
- Nonoptimal vaginal microbiomes are associated with immune dysregulation, altered metabolite profiles, and compromised epithelial barrier function.
- These changes create a more permissive environment for HIV infection.
- Despite identified mechanisms, effective interventions to restore a healthy vaginal microbiome and immunity are currently lacking.
Conclusions:
- Developing women-centered strategies to modulate the vaginal microbiome and its metabolites is essential for reducing HIV acquisition.
- Further research is needed to translate current findings into safe and effective treatments.
- Targeting the vaginal microbiome represents a promising avenue for HIV prevention.
Related Concept Videos
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Sexually Transmitted Infections
Retrovirus Life Cycles
Viral Mutations

